Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease;
Leonard, F, Srinivasan, S, Liu, X, Collnot, EM, Ferrari, M, Lehr, CM & Godin, B 2020, European Journal of Pharmaceutics and Biopharmaceutics, vol. 151, pp. 61-72.

Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization;
Leonard, F, Curtis, LT, Hamed, AR, Zhang, C, Chau, E, Sieving, D, Godin, B & Frieboes, HB 2020, Cancer Immunology, Immunotherapy, vol. 69, no. 5, pp. 731-744.

Evaluation of Single-Cell Cytokine Secretion and Cell-Cell Interactions with a Hierarchical Loading Microwell Chip;
Zhou, Y, Shao, N, Bessa de Castro, R, Zhang, P, Ma, Y, Liu, X, Huang, F, Wang, R & Qin, L 2020, Cell Reports, vol. 31, no. 4, 107574.

Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide;
Hu, Z, Nizzero, S, Goel, S, Hinkle, LE, Wu, X, Li, C, Ferrari, M & Shen, H 2020, Science Advances, vol. 6, no. 14, eaba0145.

xosomes as a novel immunotherapeutic approach for metastatic ovarian cancer treatment.;
Pisano, S, Gonzalez, D, Ferrari, M, Conlan, RS & Corradetti, B 2020, Advanced Cancer Therapies, Society of Surgical Oncology (SSO), Orlando, United States, 2/16/20 - 2/17/21, .

Biocompatible PLGA-mesoporous silicon microspheres for the controlled release of bmp-2 for bone augmentation;
Minardi, S, Fernandez-Moure, JS, Fan, D, Murphy, MB, Yazdi, IK, Liu, X, Weiner, BK & Tasciotti, E 2020, Pharmaceutics, vol. 12, no. 2, 118.

Immuntherapeutika gegen Kopf-Hals-Plattenepithelkarzinom-Stammzellen;
Qian, X, Leonard, F, Wenhao, Y, Sudhoff, H, Hoffmann, TK, Ferrone, S, Kaufmann, AM & Albers, AE 2020, HNO, vol. 68, no. 2, pp. 94-99.

Spirituality and Sustaining Hope in Adolescents with Cancer: The Patients' View;
Proserpio, T, Pagani Bagliacca, E, Sironi, G, Clerici, CA, Veneroni, L, Massimino, M & Ferrari, A 2020, Journal of Adolescent and Young Adult Oncology, vol. 9, no. 1, pp. 36-40.
Live Chat Available